Moreover, the 36-month beta value for ELAN is 0.96. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 8 as “hold,” and 1 as “sell.”
The average price recommended by analysts for Elanco Animal Health Incorporated (ELAN) is $15.06, which is $5.92 above the current market price. The public float for ELAN is 472.91M and currently, short sellers hold a 2.95% of that float. On March 17, 2023, ELAN’s average trading volume was 7.29M shares.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
ELAN) stock’s latest price update
Elanco Animal Health Incorporated (NYSE: ELAN)’s stock price has increased by 2.01 compared to its previous closing price of 9.45. Nevertheless, the company has seen a loss of -4.65% in its stock price over the last five trading days. MarketWatch.com reported on 02/26/22 that Not enough babies? EV battery shortage? Dwindling water? There are ‘scarcity’ stock plays for all of it
ELAN’s Market Performance
ELAN’s stock has fallen by -4.65% in the past week, with a monthly drop of -25.21% and a quarterly drop of -26.30%. The volatility ratio for the week is 5.00% while the volatility levels for the last 30 days are 4.21% for Elanco Animal Health Incorporated The simple moving average for the last 20 days is -13.82% for ELAN stock, with a simple moving average of -36.36% for the last 200 days.
Analysts’ Opinion of ELAN
Many brokerage firms have already submitted their reports for ELAN stocks, with Morgan Stanley repeating the rating for ELAN by listing it as a “Equal-Weight.” The predicted price for ELAN in the upcoming period, according to Morgan Stanley is $22 based on the research report published on August 18th of the previous year 2022.
JP Morgan, on the other hand, stated in their research note that they expect to see ELAN reach a price target of $24, previously predicting the price at $28. The rating they have provided for ELAN stocks is “Neutral” according to the report published on August 16th, 2022.
Goldman gave a rating of “Sell” to ELAN, setting the target price at $19 in the report published on July 21st of the previous year.
ELAN Trading at -22.43% from the 50-Day Moving Average
After a stumble in the market that brought ELAN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -65.17% of loss for the given period.
Volatility was left at 4.21%, however, over the last 30 days, the volatility rate increased by 5.00%, as shares sank -28.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -21.94% lower at present.
During the last 5 trading sessions, ELAN fell by -4.65%, which changed the moving average for the period of 200-days by -59.61% in comparison to the 20-day moving average, which settled at $11.00. In addition, Elanco Animal Health Incorporated saw -21.11% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ELAN starting from HOOVER R DAVID, who purchase 5,000 shares at the price of $9.55 back on Mar 14. After this action, HOOVER R DAVID now owns 165,000 shares of Elanco Animal Health Incorporated, valued at $47,750 using the latest closing price.
HOOVER R DAVID, the Director of Elanco Animal Health Incorporated, purchase 5,000 shares at $9.46 during a trade that took place back on Mar 13, which means that HOOVER R DAVID is holding 160,000 shares at $47,288 based on the most recent closing price.
Stock Fundamentals for ELAN
Current profitability levels for the company are sitting at:
- +6.34 for the present operating margin
- +43.55 for the gross margin
The net margin for Elanco Animal Health Incorporated stands at -9.91. Equity return is now at value -1.10, with -0.50 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.99.
Conclusion
To wrap up, the performance of Elanco Animal Health Incorporated (ELAN) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
